A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure

Background: High-flow nasal cannula (HFNC) has been recommended as a suitable choice for the management of coronavirus disease 2019 (COVID-19) patients with acute hypoxemic respiratory failure before mechanical ventilation (MV); however, delaying MV with HFNC therapy is still a dilemma between the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiqian, Yang, Xiaobo, Huang, Chaolin, Zou, Xiaojing, Zhou, Ting, Pan, Shangwen, Yang, Luyu, Wu, Yongran, Ouyang, Yaqi, Wang, Yaxin, Xu, Dan, Zhao, Xin, Shu, Huaqing, Jiang, Yongxiang, Xiong, Wei, Ren, Lehao, Liu, Hong, Yuan, Yin, Qi, Hong, Fu, Shouzhi, Chen, Dechang, Zhang, Dingyu, Yuan, Shiying, Shang, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793962/
https://www.ncbi.nlm.nih.gov/pubmed/33425951
http://dx.doi.org/10.3389/fmed.2020.607821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793962/
https://www.ncbi.nlm.nih.gov/pubmed/33425951
http://dx.doi.org/10.3389/fmed.2020.607821

Ejemplares similares